Cite

HARVARD Citation

    Xu, L. et al. (2022). Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade. Journal for immunotherapy of cancer. 10 (12), p. . [Online]. 
  
Back to record